Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 2056 AL 2070

Multiple approaches for the management of Alzheimer disease: Natural compounds, FDA approved drugs, and nanotechnology interventions

Leena Esam Azhar, Abdulrahman Esam Azhar, Najiah Esam Azhar.

Cell Mol Biol (Noisy-le-grand). 2022 Nov 30;68(11):8-15. doi: 10.14715/cmb/2022.68.11.2.

Objectives, Outcomes, Facilitators, and Barriers of Telemedicine Systems for Patients with Alzheimer's Disease and their Caregivers and Care Providers: A Systematic Review

Amiri P, Niazkhani Z, Pirnejad H, ShojaeiBaghini M, Bahaadinbeigy K.

Arch Iran Med. 2022 Aug 1;25(8):564-573. doi: 10.34172/aim.2022.90.

New treatment approaches for Alzheimer's disease: preclinical studies and clinical trials centered on antidiabetic drugs

Katsenos AP, Davri AS, Simos YV, Nikas IP, Bekiari C, Paschou SA, Peschos D, Konitsiotis S, Vezyraki P, Tsamis KI.

Expert Opin Investig Drugs. 2022 Jan;31(1):105-123. doi: 10.1080/13543784.2022.2022122. Epub 2022 Jan 2.

Effects of Medicare comprehensive medication review on racial/ethnic disparities in nonadherence to statin medications among patients with Alzheimer's Disease: an observational analysis

Browning JA, Tsang CCS, Dong X, Wan JY, Chisholm-Burns MA, Finch CK, Tsao JW, Liu C, Wang J.

BMC Health Serv Res. 2022 Feb 7;22(1):159. doi: 10.1186/s12913-022-07483-8.

AD and its comorbidities: An obstacle to develop a clinically efficient treatment?

Baker J, Schott JM.

Rev Neurol (Paris). 2022 May;178(5):450-459. doi: 10.1016/j.neurol.2022.03.001. Epub 2022 May 2.

Association Between Metformin and Alzheimer's Disease: A Systematic Review and Meta-Analysis of Clinical Observational Studies

Luo A, Ning P, Lu H, Huang H, Shen Q, Zhang D, Xu F, Yang L, Xu Y.

J Alzheimers Dis. 2022;88(4):1311-1323. doi: 10.3233/JAD-220180.

Did the COVID-19 Pandemic Affect the Use of Antipsychotics Among Nursing Home Residents With ADRD?

Yan D, Temkin-Greener H, Cai S.

Am J Geriatr Psychiatry. 2023 Feb;31(2):124-140. doi: 10.1016/j.jagp.2022.09.009. Epub 2022 Sep 28.

Chronic pain in Alzheimer's disease: Endocannabinoid system

Blanton H, Reddy PH, Benamar K.

Exp Neurol. 2023 Feb;360:114287. doi: 10.1016/j.expneurol.2022.114287. Epub 2022 Nov 29.

Recruitment and Screening Methods in Alzheimer's Disease Research: The FIT-AD Trial

Greimel S, Wyman JF, Zhang L, Yu F.

J Gerontol A Biol Sci Med Sci. 2022 Mar 3;77(3):547-553. doi: 10.1093/gerona/glab092.

Amyloid-Related Imaging Abnormalities in 2 Phase 3 Studies Evaluating Aducanumab in Patients With Early Alzheimer Disease

Salloway S, Chalkias S, Barkhof F, Burkett P, Barakos J, Purcell D, Suhy J, Forrestal F, Tian Y, Umans K, Wang G, Singhal P, Budd Haeberlein S, Smirnakis K.

JAMA Neurol. 2022 Jan 1;79(1):13-21. doi: 10.1001/jamaneurol.2021.4161.

Theranostic Applications of Nanomaterials in Alzheimer's Disease: A Multifunctional Approach

Tripathi P, Shukla P, Bieberich E.

Curr Pharm Des. 2022;28(2):116-132. doi: 10.2174/1381612827666211122153946.

The Efficacy and Safety of Alzheimer's Disease Therapies: An Updated Umbrella Review

Fan F, Liu H, Shi X, Ai Y, Liu Q, Cheng Y.

J Alzheimers Dis. 2022;85(3):1195-1204. doi: 10.3233/JAD-215423.

Stem Cell-based Therapeutic and Diagnostic Approaches in Alzheimer's Disease

Abdi S, Javanmehr N, Ghasemi-Kasman M, Bali HY, Pirzadeh M.

Curr Neuropharmacol. 2022;20(6):1093-1115. doi: 10.2174/1570159X20666211231090659.

Psychosis in Alzheimer disease - mechanisms, genetics and therapeutic opportunities

Ismail Z, Creese B, Aarsland D, Kales HC, Lyketsos CG, Sweet RA, Ballard C.

Nat Rev Neurol. 2022 Mar;18(3):131-144. doi: 10.1038/s41582-021-00597-3. Epub 2022 Jan 4.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias